{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:51:37Z","timestamp":1781920297463,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40290-025-00554-1","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:46:51Z","timestamp":1741117611000},"page":"125-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Suggested Improvements to the Current East African Community Medicines Regulatory Harmonization Joint Review Process and a Proposed New Review Model for this Initiative"],"prefix":"10.1007","volume":"39","author":[{"given":"Nancy","family":"Ngum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimwemwe","family":"Chamdimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedith","family":"Mbonyingingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Siyoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawien","family":"Atem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Fimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nahamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burhani","family":"Simai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-5699","authenticated-orcid":false,"given":"Sam","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"key":"554_CR1","unstructured":"East African Community. EAC Overview. https:\/\/www.eac.int\/overview-of-eac. Accessed 6 Feb 2025."},{"key":"554_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105497","author":"N Ngum","year":"2023","unstructured":"Ngum N, Ndomondo-Sigonda M, Walker S, Salek S. Regional regulatory harmonisation initiatives: their potential contribution to the newly established African Medicines Agency. Regul Toxicol Pharmacol. 2023. https:\/\/doi.org\/10.1016\/j.yrtph.2023.105497.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"8","key":"554_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003134","volume":"17","author":"JH Mashingia","year":"2020","unstructured":"Mashingia JH, Ahonkhai V, Aineplan N, Ambali A, Angole A, Arik M, et al. Eight years of the East African Community Medicines Regulatory Harmonisation initiative: implementation, progress, and lessons learned. PLoS Med. 2020;17(8): e1003134. https:\/\/doi.org\/10.1371\/journal.pmed.1003134.","journal-title":"PLoS Med"},{"key":"554_CR4","doi-asserted-by":"publisher","first-page":"1117439","DOI":"10.3389\/fmed.2023.1117439","volume":"10","author":"BM Ncube","year":"2023","unstructured":"Ncube BM, Dube A, Ward K. The domestication of the African Union model law on medical products regulation: perceived benefits, enabling factors, and challenges. Front Med. 2023;10:1117439. https:\/\/doi.org\/10.3389\/fmed.2023.1117439.","journal-title":"Front Med"},{"key":"554_CR5","doi-asserted-by":"publisher","first-page":"891506","DOI":"10.3389\/fphar.2022.891506","volume":"13","author":"N Ngum","year":"2022","unstructured":"Ngum N, Mashingia J, Ndomondo-Sigonda M, Walker S, Salek S. Evaluation of the effectiveness and efficiency of the East African Community joint assessment procedure by member countries: the way forward. Front Pharmacol. 2022;13:891506. https:\/\/doi.org\/10.3389\/fphar.2022.891506.","journal-title":"Front Pharmacol"},{"issue":"8","key":"554_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003099","volume":"17","author":"M Ndomondo-Sigonda","year":"2020","unstructured":"Ndomondo-Sigonda M, Mahlangu G, Agama-Anyetei M, Cooke E. A new approach to an old problem: overview of the East African community\u2019s medicines regulatory harmonization initiative. PLoS Med. 2020;17(8): e1003099. https:\/\/doi.org\/10.1371\/journal.pmed.1003099.","journal-title":"PLoS Med"},{"key":"554_CR7","doi-asserted-by":"publisher","first-page":"891506","DOI":"10.3389\/fphar.2022.891506","volume":"13","author":"N Ngum","year":"2022","unstructured":"Ngum N, Mashingia J, Ndomondo-Sigonda M, Walker S, Salek S. Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: opportunities for improvement. Front Pharmacol. 2022;13:891506. https:\/\/doi.org\/10.3389\/fphar.2022.891506.","journal-title":"Front Pharmacol"},{"issue":"3","key":"554_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/009286150904300314","volume":"43","author":"N McAuslane","year":"2009","unstructured":"McAuslane N, Cone M, Collins J, Walker S. Emerging markets and emerging agencies: a comparative study of how key regulatory agencies in Asia, Latin America, the Middle East, and Africa are developing regulatory processes and review models for new medical products. Drug Inf J. 2009;43(3):349\u201359.","journal-title":"Drug Inf J"},{"key":"554_CR9","doi-asserted-by":"publisher","first-page":"1437970","DOI":"10.3389\/fmed.2024.1437970","volume":"11","author":"N Ngum","year":"2024","unstructured":"Ngum N, Ndomondo-Sigonda M, Habonimana R, Siyoi F, Irasabwa C, Ojukwu J, Apolinary F, Okello A, Ahmada S, Walker S, Salek S. Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency. Front Med. 2024;11:1437970. https:\/\/doi.org\/10.3389\/fmed.2024.1437970.","journal-title":"Front Med"},{"key":"554_CR10","doi-asserted-by":"publisher","first-page":"1438041","DOI":"10.3389\/fmed.2024.1438041","volume":"11","author":"N Ngum","year":"2024","unstructured":"Ngum N, Ndomondo-Sigonda M, Habonimana R, Siyoi F, Irasabwa C, Ojukwu J, Apolinary F, Okello A, Ahmada S, Walker S, Salek S. Evaluation of the review models and approval timelines of authorities participating in the East African Medicine Regulatory Harmonisation initiative: alignment and strategies for moving forward. Front Med. 2024;11:1438041. https:\/\/doi.org\/10.3389\/fmed.2024.1438041.","journal-title":"Front Med"},{"key":"554_CR11","doi-asserted-by":"publisher","DOI":"10.34172\/ijhpm.2024.8070","author":"T Sithole","year":"2024","unstructured":"Sithole T, Ngum N, Owusu-Asante M, Salek S, Walker S. Comparison of three regional medicines regulatory harmonisation initiatives in Africa: opportunities for improvement and alignment. Int J Health Policy Manag. 2024. https:\/\/doi.org\/10.34172\/ijhpm.2024.8070.","journal-title":"Int J Health Policy Manag"},{"key":"554_CR12","unstructured":"AUDA-NEPAD. The African Union Model Law of Medical Products Regulation. 2017. https:\/\/adphealth.org\/upload\/resource\/African_Union_AU_Model_Law.pdf. Accessed 15 Apr 2024."},{"key":"554_CR13","unstructured":"AUDA-NEPAD. African Union Model Law on Medical Products Regulation. 2021. https:\/\/www.nepad.org\/publication\/au-model-law-medical-products-regulation Accessed 15 Apr 2024."},{"key":"554_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/2168479014547421","volume":"49","author":"S Walker","year":"2015","unstructured":"Walker S, McAuslane N, Liberti L, et al. A universal framework for the benefit-risk assessment of medicines: is this the way forward? Ther Innov Regul Sci. 2015;49:17. https:\/\/doi.org\/10.1177\/2168479014547421.","journal-title":"Ther Innov Regul Sci."},{"key":"554_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fphar.2015.00099","volume":"6","author":"J Leong","year":"2015","unstructured":"Leong J, Walker S, Salek S. A practical approach to communicating benefit-risk decisions of medicines to stakeholders. Front Pharmacol. 2015;6:99. https:\/\/doi.org\/10.3389\/fphar.2015.00099.","journal-title":"Front Pharmacol"},{"key":"554_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.898743","volume":"9","author":"T Sithole","year":"2022","unstructured":"Sithole T, Mahlangu G, Walker S, Salek S. Regulatory authority evaluation of the effectiveness and efficiency of the ZaZiBoNa Collaborative Medicines Registration initiative: the way forward. Front Med (Lausanne). 2022;9: 898743. https:\/\/doi.org\/10.3389\/fmed.2022.898743.","journal-title":"Front Med (Lausanne)"},{"key":"554_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/2168479017696260","author":"N McAuslane","year":"2017","unstructured":"McAuslane N, Leong J, Liberti L, Walker S. The benefit-risk assessment of nedicines: experience of a consortium of medium-sized regulatory authorities. Ther Innov Regul Sci. 2017. https:\/\/doi.org\/10.1177\/2168479017696260.","journal-title":"Ther Innov Regul Sci"},{"key":"554_CR18","doi-asserted-by":"publisher","first-page":"1265058","DOI":"10.3389\/fmed.2023.1265058","volume":"10","author":"L Danks","year":"2023","unstructured":"Danks L, Semete-Makokotlela B, Otwombe K, Parag Y, Walker S, Salek S. Evaluation of the impact of reliance on the regulatory performance in the South African Health Products Regulatory Authority: implications for African regulatory authorities. Front Med. 2023;10:1265058. https:\/\/doi.org\/10.3389\/fmed.2023.1265058.","journal-title":"Front Med"},{"key":"554_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fphar.2016.00180J","volume":"7","author":"R Donelan","year":"2016","unstructured":"Donelan R, Walker S, Salek S. The development and validation of a generic instrument, QoDoS, for assessing the quality of decision making. Front Pharmacol. 2016;7:180. https:\/\/doi.org\/10.3389\/fphar.2016.00180J.","journal-title":"Front Pharmacol"},{"key":"554_CR20","unstructured":"Centre for Innovation in Regulatory Science. CIRS RD Briefing 74\u2014OpERA programme. 2021; https:\/\/cirsci.org\/wp-content\/uploads\/2020\/02\/CIRS-RD-Briefing-74-OpERA-programme.pdf. Accessed 15 Apr 2024."},{"key":"554_CR21","unstructured":"WHO Technical Report Series NO 1033, of Good Reliance Practices in the regulation of medical products 2021. https:\/\/cdn.who.int\/media\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/inspections\/grelp-annex-10-trs-1033\/trs1033_annex10-good-reliance-practices.pdf?sfvrsn=dd5502cb_17&download=true. Accessed 15 Apr 2024."},{"key":"554_CR22","unstructured":"East African Community. EAC Medicines Regulatory Guidelines. https:\/\/www.eac.int\/medicines-regulatory-guidelines. Accessed 15 Apr 2024."},{"issue":"8","key":"554_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003099","volume":"17","author":"H Sillo","year":"2020","unstructured":"Sillo H, Ambali A, Azatyan S, Chamdimba C, Kaale E, Kabatende J, et al. Coming together to improve access to medicines: the genesis of the East African Community\u2019s Medicines Regulatory Harmonization initiative. PLoS Med. 2020;17(8): e1003133. https:\/\/doi.org\/10.1371\/journal.pmed.1003099.","journal-title":"PLoS Med"},{"issue":"8","key":"554_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003129","volume":"17","author":"M Arik","year":"2020","unstructured":"Arik M, Bamenyekanye E, Fimbo A, Kabatende J, Kijo AS, Simai B, Siyoi F, Azatyan S, Ambali A, Cooke E, Mashingia JH, Mwesigye JP, Ndomondo-Sigonda M, Sillo H, Sonoiya S, Tanui P, Ward M, Delano T. Optimizing the East African Community\u2019s Medicines Regulatory Harmonization initiative in 2020\u20132022: a Roadmap for the Future. PLoS Med. 2020;17(8): e1003129. https:\/\/doi.org\/10.1371\/journal.pmed.1003129.","journal-title":"PLoS Med"},{"key":"554_CR25","unstructured":"SAHPRA. SAHPRA invests in capacity building. https:\/\/www.sahpra.org.za\/news-and-updates\/sahpra-invests-in-capacity-building-announcing-new-graduates. Accessed 7 Feb 2025."}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-025-00554-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-025-00554-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-025-00554-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T09:41:54Z","timestamp":1744018914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-025-00554-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["554"],"URL":"https:\/\/doi.org\/10.1007\/s40290-025-00554-1","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"10 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supported by an unrestricted grant from the Gates Foundation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article. Sam Salek and Stuart Walker are Editorial Board members of Pharmaceutical Medicine. Profs. Salek and Walker were not involved in the selection of peer reviewers for the manuscript, nor any of the subsequent editorial decisions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Health Science Engineering and Technology ECDA, University of Hertfordshire, United Kingdom [Reference Protocol Number: LMS\/PGR\/UH\/04988].","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The study participants provided implicit consent for taking part in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data supporting the results reported in the manuscript can be obtained from the authors.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The software application or custom code can be obtained from the authors, if applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"NN designed the study, collected, and interpreted the results and wrote the draft of the manuscript. CC provided data and reviewed the draft of the manuscript.\u00a0DM provided data and reviewed the draft of the manuscript. FS provided data and reviewed the draft of the manuscript. EB provided data and reviewed the draft of the manuscript. MA provided data and reviewed the draft of the manuscript. AF provided data and reviewed the draft of the manuscript. DN provided data and reviewed the draft of the manuscript. BS provided data and reviewed the draft of the manuscript. SW designed the study, interpreted the results, and reviewed the draft of the manuscript. SS designed the study, interpreted the results, and reviewed the draft of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}